Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
268
Views
7
CrossRef citations to date
0
Altmetric
Short Communications

Phytochemical and pharmacological appraisal of the aerial parts of Lotus corniculatus L. growing in Egypt

, , , , , , , & show all
Pages 5914-5917 | Received 05 May 2020, Accepted 13 Jul 2020, Published online: 05 Aug 2020
 

Abstract

Lotus corniculatus L. (Fabaceae) is widely grown in Egypt. It has a great history of folkloric medicinal uses. All fractions of aerial parts of L. corniculatus L. showed significant antioxidant and immunostimulant activities and could strongly induce lymphoproliferation. However, the light petrol fraction had antifungal activity against C. neoformans with IC50 value (<8 µg/mL) and exhibited strongest in-vitro antiprotozoal activity against protozoan parasites belonging to the genera Trypanosoma with IC50 value (0.98 µg/mL) and Plasmodium (with 100% inhibition using a sample concentration of 15866.7 ng/mL). This is the first study of the immunostimulant and antiprotozoal activities of genus Lotus. By this approach, it was possible to isolate eight compounds (-)-7,2'-dihydroxy-4'-methoxyisoflavan (vestitol) (1), kaempferol (2), kaempferol 3-O-α-L-rhamnoside (afzelin) (3), kaempferol 3, 7-O-α-L-dirhamnoside (kaempferitin) (4), kaempferol-3-O-[β-D-xylopyranosyl (1″′→2″)-β-D-galactopyranoside] (5), 3-O-[β-D-glucuronopyranosyl] soyasapogenol B (6), kaempferol-3-O-[β-D-xylopyranosyl (1″′→2″)-β-D-galactopyranoside]-7-O-α-L-rhamnopyranoside (7) and 3-O-[α-L-rhamnopyranosyl (1″′→2″)-β-D-galactopyranosyl-(1″→2′)-β-D-glucuronopyranosyl] soyasapogenol B (soyasaponin І) (8).

Acknowledgment

We are thankful to Dr Baharthi Avula for HRESIMS and to Alexandria University for funding.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.